- £3.42bn
- £4.40bn
- $3.16bn
- 75
- 65
- 48
- 72
REG - Hikma Pharmaceutical - Directorate Change
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Hikma launches Icosapent Ethyl Capsules
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Notice to Bondholders
AnnouncementREG - Hikma Pharmaceutical - Blocklisting Application
AnnouncementREG - Hikma Pharmaceutical - Block listing Interim Review
AnnouncementREG - Hikma Pharmaceutical - Hikma updates on ANDA for generic Advair Diskus®
AnnouncementREG - Hikma Pharmaceutical - Hikma receives favourable court ruling
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Half-year Report
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Notice of Results
AnnouncementREG - Hikma Pharmaceutical - Publication of Offering Circular
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Directorate Change
AnnouncementREG - FTSE Russell Hikma Pharmaceutical - Hikma Pharmaceuticals
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
Announcement